PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: PEPTIDES+ (ANTI-AGING)
DRUG NAME: RAPAMYCIN
FDA Safety Data Sheet can be found here.
Roark KM. Rapamycin for longevity: the pros, the cons, and future perspectives. Front Aging. 2025 [PubMed Link]
Sanada F, Hayashi S, Morishita R. Targeting the hallmarks of aging: mechanisms and therapeutic opportunities. Front Cardiovasc Med. 2025 [PubMed Link]
Chen Q. Game changer: Navigating between challenges and hopes in geropharmacology. Adv Pharmacol. 2025 [PubMed Link]
Raghuvanshi K. Exploring the role of mTOR pathway in aging and age-related disorders. EXCLI J. 2025 [PubMed Link]
Trisal A. Clinical Insights on Caloric Restriction Mimetics for Mitigating Brain Aging and Related Neurodegeneration. Cell Mol Neurobiol. 2024 [PubMed Link]
Falvino A. Which Approach to Choose to Counteract Musculoskeletal Aging? A Comprehensive Review on the Multiple Effects of Exercise. Int J Mol Sci. 2025 [PubMed Link]
Fu W. Targeting mTOR for Anti-Aging and Anti-Cancer Therapy. Molecules. 2023 [PubMed Link]
Du N. Anti-Aging Drugs and the Related Signal Pathways. Biomedicines. 2024 [PubMed Link]
Stojić V. New anti-aging strategies: a narrative review. Acta Dermatovenerol Alp Pannonica Adriat. 2023 [PubMed Link]
Li Z. Aging and age-related diseases: from mechanisms to therapeutic strategies. Biogerontology. 2021 [PubMed Link]
Zhang Y. The Role of Rapamycin in Healthspan Extension via the Delay of Organ Aging. Ageing Res Rev. 2021 [PubMed Link]
Ganesh SK. Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus. Mol Biol Rep. 2023 [PubMed Link]
Ghosh Chowdhury S. Relating aging and autophagy: a new perspective towards the welfare of human health. EXCLI J. 2023 [PubMed Link]
De Sousa Lages A. Therapeutics That Can Potentially Replicate or Augment the Anti-Aging Effects of Physical Exercise. Int J Mol Sci. 2022 [PubMed Link]